Philip Morris International is no longer asking the market to take the smoke-free conversion on faith. The second quarter was the first time quarterly net revenues cleared eleven billion, and smoke-free already contributes about forty-two percent of the mix. Combustibles still throw off the cash that funds IQOS, ZYN, and VEEV, which is why the equity now trades like a growth staple rather than a fading cigarette franchise. The investment debate is whether that conversion stays fast enough to defend a premium multiple after a print that already looks priced for continued high-single-digit compounding.
Adjusted diluted earnings of $2.20 rose more than fifteen percent. Reported earnings of $1.80 fell on a non-cash Rothmans Benson & Hedges write-down. Organic operating income still expanded at a double-digit clip, and international smoke-free volume grew even after a Japan excise shock and a Poland flavor ban. United States ZYN shipments recovered sequentially, but offtake was only broadly stable. Combustible pricing is the hidden pillar. It is what lets management lift the dividend and still aim for leverage near two times.
The next few quarters resolve whether IQOS in-market sales reaccelerate once Japan pantry effects fade, whether ZYN ULTRA and stepped-up American investment lift offtake rather than just shipments, and whether the September dividend increase sits comfortably inside the cash engine. The third-quarter adjusted earnings guide starts at $2.20. The top of that band is $2.25 and sits below Street hopes. That gap, not the second-quarter beat, is what the multiple now has to live with.